Intravitreal Anti-VEGF Therapy

Intravitreal anti-VEGF therapy involves injecting medications directly into the eye to block vascular endothelial growth factor (VEGF), a protein that promotes abnormal blood vessel growth and leakage. This treatment is commonly used for eye conditions like age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion, which can cause vision loss due to fluid buildup or bleeding in the retina. By inhibiting VEGF, the therapy helps reduce swelling, slow disease progression, and often improve or stabilize vision. The procedure is performed under local anesthesia and is generally safe, with regular injections tailored to the patient's needs.